Reuters -- Depomed Inc (DEPO.O) said it delivered its first formulation to medical products maker Covidien (COV.N), triggering a milestone payment of $500,000 under its licensing deal with the company.
Reuters -- Depomed Inc (DEPO.O) said it delivered its first formulation to medical products maker Covidien (COV.N), triggering a milestone payment of $500,000 under its licensing deal with the company.
